+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

HIV Drugs Market Report 2025 - Product Thumbnail Image

HIV Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Region, 2025-2033 - Product Thumbnail Image

HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Region, 2025-2033

  • Report
  • June 2025
  • 138 Pages
  • Global
From
HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 164 Pages
  • Global
From
North America HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Country, 2025-2033 - Product Thumbnail Image

North America HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Country, 2025-2033

  • Report
  • August 2025
  • 122 Pages
  • North America
From
Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2025 - Product Thumbnail Image

Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030 - Product Thumbnail Image

HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030

  • Report
  • February 2025
  • 274 Pages
  • Global
From
HIV-related Lymphoma Drug Market by Drug Class (Combination Therapies, Monoclonal Antibodies, Small Molecule Inhibitors), Treatment Line (First Line, Second Line, Third Line and Above), Mechanism of Action, Administration Route, End User - Global Forecast 2025-2030 - Product Thumbnail Image

HIV-related Lymphoma Drug Market by Drug Class (Combination Therapies, Monoclonal Antibodies, Small Molecule Inhibitors), Treatment Line (First Line, Second Line, Third Line and Above), Mechanism of Action, Administration Route, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Ubenimex Capsules Market by Indication (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Lymphoma), Strength (100 Mg, 200 Mg, 50 Mg), End User, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Ubenimex Capsules Market by Indication (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Lymphoma), Strength (100 Mg, 200 Mg, 50 Mg), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Integrase Inhibitors Market by Route Of Administration (Injectable, Oral), Brand Status (Branded, Generic), Patient Population, Distribution Channel, Compound - Global Forecast 2025-2030 - Product Thumbnail Image

Integrase Inhibitors Market by Route Of Administration (Injectable, Oral), Brand Status (Branded, Generic), Patient Population, Distribution Channel, Compound - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
HIV Entry Inhibitors Market by Mechanism of Action (Ccr5 Antagonists, Fusion Inhibitors, Post-Attachment Inhibitors), Route of Administration (Injectable, Oral), End User, Distribution Channel, Patient Type - Global Forecast 2025-2030 - Product Thumbnail Image

HIV Entry Inhibitors Market by Mechanism of Action (Ccr5 Antagonists, Fusion Inhibitors, Post-Attachment Inhibitors), Route of Administration (Injectable, Oral), End User, Distribution Channel, Patient Type - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
Lamivudine Drugs Market by Formulation (Injection, Oral Solution, Oral Tablet), Product Type (Combination Therapy, Single Therapy), Dosage Strength, Distribution Channel, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Lamivudine Drugs Market by Formulation (Injection, Oral Solution, Oral Tablet), Product Type (Combination Therapy, Single Therapy), Dosage Strength, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Injectable HIV Medication Market by Age Group (Adult, Pediatric), Treatment Line (First Line, Salvage, Second Line), Distribution Channel, Patient Type, End User, Drug Mechanism, Dosage Frequency, Manufacturer - Global Forecast 2025-2030 - Product Thumbnail Image

Injectable HIV Medication Market by Age Group (Adult, Pediatric), Treatment Line (First Line, Salvage, Second Line), Distribution Channel, Patient Type, End User, Drug Mechanism, Dosage Frequency, Manufacturer - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
Enfuvirtide for Injection Market by Distribution Channel (Clinics, Hospitals, Retail Pharmacies), Patient Category (Treatment Experienced, Treatment Naive), Age Group, Therapy Line, Dosage Form, Administration Setting - Global Forecast 2025-2030 - Product Thumbnail Image

Enfuvirtide for Injection Market by Distribution Channel (Clinics, Hospitals, Retail Pharmacies), Patient Category (Treatment Experienced, Treatment Naive), Age Group, Therapy Line, Dosage Form, Administration Setting - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Raltegravir Potassium Drugs Market by Product Type (Brand, Generic), Dosage Strength (400 Mg, 600 Mg), Dosage Form, Distribution Channel, Patient Type - Global Forecast 2025-2030 - Product Thumbnail Image

Raltegravir Potassium Drugs Market by Product Type (Brand, Generic), Dosage Strength (400 Mg, 600 Mg), Dosage Form, Distribution Channel, Patient Type - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
HIV Antivirals Market by Drug Class (CCR5 Antagonists, Fusion Inhibitors, Integrase Strand Transfer Inhibitors), Product Type (Fixed Dose Combination, Single Agent), Distribution Channel, Formulation Type, Therapy Line, Brand Type, Patient Age Group - Global Forecast 2025-2030 - Product Thumbnail Image

HIV Antivirals Market by Drug Class (CCR5 Antagonists, Fusion Inhibitors, Integrase Strand Transfer Inhibitors), Product Type (Fixed Dose Combination, Single Agent), Distribution Channel, Formulation Type, Therapy Line, Brand Type, Patient Age Group - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Anti-Retroviral Drugs Market by Product Type (Ccr5 Antagonists, Fusion Inhibitors, Integrase Strand Transfer Inhibitors), Route Of Administration (Oral, Parenteral), Formulation, End User, Distribution Channel, Therapy Line, Patient Group - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-Retroviral Drugs Market by Product Type (Ccr5 Antagonists, Fusion Inhibitors, Integrase Strand Transfer Inhibitors), Route Of Administration (Oral, Parenteral), Formulation, End User, Distribution Channel, Therapy Line, Patient Group - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Etravirine Market by Dosage Form (Film-Coated Tablet), Competition Type (Branded, Generic), Packaging, End User, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Etravirine Market by Dosage Form (Film-Coated Tablet), Competition Type (Branded, Generic), Packaging, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Tenofovir Disoproxil Fumarate Tablets Market by Dosage Strength (150 Mg, 300 Mg), Product Type (Branded, Generic), Treatment Regimen, Distribution Channel, Indication, Packaging Type - Global Forecast 2025-2030 - Product Thumbnail Image

Tenofovir Disoproxil Fumarate Tablets Market by Dosage Strength (150 Mg, 300 Mg), Product Type (Branded, Generic), Treatment Regimen, Distribution Channel, Indication, Packaging Type - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Pre-Exposure Prophylaxis Market by Product Type (Branded, Generic), Form (Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Pre-Exposure Prophylaxis Market by Product Type (Branded, Generic), Form (Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Injectable HIV Treatment Market by Product Type (Cabotegravir, Cabotegravir Plus Rilpivirine, Islatravir), Dosing Frequency (One Month, Three Months or More, Two Months), Patient Experience, End User, Distribution Channel, Age Group - Global Forecast 2025-2030 - Product Thumbnail Image

Injectable HIV Treatment Market by Product Type (Cabotegravir, Cabotegravir Plus Rilpivirine, Islatravir), Dosing Frequency (One Month, Three Months or More, Two Months), Patient Experience, End User, Distribution Channel, Age Group - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more